Company portrait
Opna Immuno-Oncology SA (Opna-IO) is a biotechnology company recently spun-off from the Swiss Institute of Experimental Cancer Research within the École Polytechnique Fédérale de Lausanne (EPFL). The Company is developing first in-class therapies to disrupt immuno-suppressive barriers in cancer cells so as to enhance the capability of the body’s immune system to attack human tumors.
Job offers
There are no vacancies at the moment.
Keep an eye on this company by adding it to your Favorites.
